a public good project by the
Synthesis
Company
of California

© 2026

Cleo-Aron Weiß | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Cleo-Aron Weiß

Heidelberg University(DE)University Hospital Heidelberg(DE)University Medical Centre Mannheim(DE)

Research Areas

Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Immunotherapy and Immune Responses

Most-Cited Works

→ Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab(2018)102 cited